The Filing Desk

Axogen vs Cerus

Axogen AXGN · Cerus CERS · Health Care Equipment

Cerus reported revenue of $234 million in fiscal 2025, about the same as Axogen's $225 million in fiscal 2025. Axogen's revenue grew 20.2% in its latest year, and Cerus' grew 16.1%. Axogen had an operating margin of -3.5%, against -3.7% at Cerus. Free cash flow was −$3 million at Axogen and $1 million at Cerus.

Side by side

AxogenCerus
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$225M$234M
Revenue growth20.2%16.1%
Revenue growth a year, last 5 years14.9%15.4%
Gross margin74.3%—
Operating margin−3.5%−3.7%
Net margin−7.0%−6.7%
Free cash flow−$3M$1M
Free cash flow margin−1.3%0.5%
Return on capital−4.9%—
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count4.0%3.3%
Last close$55.93$1.99
P/E at the last close——
Insider trades, last 12 monthssold $17.1 million—
Piotroski F-score5 of 9—
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
AxogenCerus
Operating margin
Percent of revenue
AxogenCerus
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
AxogenCerus

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Axogen and Cerus pages.